39 related articles for article (PubMed ID: 31045892)
1. Effect of Progestin Usage on the Interpretation of Cervical High-grade Squamous Intraepithelial Lesion.
Wang Y; Chen H; Jiang Q; Luo R; Zhou P; Wang Y; Zhao R; Fadare O; Zheng W
Am J Surg Pathol; 2019 Aug; 43(8):1066-1073. PubMed ID: 31045892
[TBL] [Abstract][Full Text] [Related]
2. Stratified mucin-producing intraepithelial lesion with invasive carcinoma: 12 cases with immunohistochemical and ultrastructural findings.
Onishi J; Sato Y; Sawaguchi A; Yamashita A; Maekawa K; Sameshima H; Asada Y
Hum Pathol; 2016 Sep; 55():174-81. PubMed ID: 27237368
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of combined high-grade squamous intraepithelial lesion and adenocarcinoma in situ of the uterine cervix: human papillomavirus genotype and methylation status and immunohistochemical study.
Kawakami F; Semba S; Itami H; Oka N; Sudo T; Ebina Y; Ohbayashi C; Mikami Y; Yokozaki H; Itoh T
Kobe J Med Sci; 2014 Nov; 60(3):E66-73. PubMed ID: 25612672
[TBL] [Abstract][Full Text] [Related]
4. Detection of HPV16 and 18 by in situ hybridization in precancerous and cancerous lesions of cervix.
Choudhury M; Singh S
Indian J Pathol Microbiol; 2006 Jul; 49(3):345-7. PubMed ID: 17001881
[TBL] [Abstract][Full Text] [Related]
5. Predictive Value of Cytokeratin 7 Immunohistochemistry in Cervical Low-grade Squamous Intraepithelial Lesion as a Marker for Risk of Progression to a High-grade Lesion.
Paquette C; Mills AM; Stoler MH
Am J Surg Pathol; 2016 Feb; 40(2):236-43. PubMed ID: 26551618
[TBL] [Abstract][Full Text] [Related]
6. AgNOR Pleomorphic Count as a Tumor Marker in Cervical Carcinogenesis and Feasibility of Its Introduction in Cervical Cancer Screening Programs to Discriminate High-Risk Cases of Squamous Intraepithelial Lesions of the Cervix.
Srivastava AN; Misra JS; Singh U; Khan M; Raza S
Acta Cytol; 2019; 63(5):371-378. PubMed ID: 31067531
[TBL] [Abstract][Full Text] [Related]
7. Expansion of Human Papillomavirus-Specific T Cells in Periphery and Cervix in a Therapeutic Vaccine Recipient Whose Cervical High-Grade Squamous Intraepithelial Lesion Regressed.
Shibata T; Shah S; Evans T; Coleman H; Lieblong BJ; Spencer HJ; Quick CM; Sasagawa T; Stephens OW; Peterson E; Johann D; Lu YC; Nakagawa M
Front Immunol; 2021; 12():645299. PubMed ID: 34659195
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials.
Yoshida T; Fukuda T; Sano T; Kanuma T; Owada N; Nakajima T
Cancer; 2004 Apr; 102(2):100-8. PubMed ID: 15098254
[TBL] [Abstract][Full Text] [Related]
9. Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia.
Keating JT; Cviko A; Riethdorf S; Riethdorf L; Quade BJ; Sun D; Duensing S; Sheets EE; Munger K; Crum CP
Am J Surg Pathol; 2001 Jul; 25(7):884-91. PubMed ID: 11420459
[TBL] [Abstract][Full Text] [Related]
10. Immunoexpression of HPV 16/18 E6 and E7 oncoproteins in high-grade cervical squamous intraepithelial lesions in HIV-positive women.
Rodrigues LC; Speck NM; Focchi GR; Schimidt MA; Marques RM; Ribalta JC
Genet Mol Res; 2016 Feb; 15(1):. PubMed ID: 26909984
[TBL] [Abstract][Full Text] [Related]
11. HPV-ISH-Negative Invasive Cervical Squamous Cell Carcinoma: Histologic and Pap Test Results.
Alexander C; White M; Maleki Z; Rodriguez EF
Acta Cytol; 2019; 63(5):417-423. PubMed ID: 31195388
[TBL] [Abstract][Full Text] [Related]
12. HPV E6/E7 mRNA In Situ Hybridization in the Diagnosis of Cervical Low-grade Squamous Intraepithelial Lesions (LSIL).
Mills AM; Coppock JD; Willis BC; Stoler MH
Am J Surg Pathol; 2018 Feb; 42(2):192-200. PubMed ID: 29112014
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Human Papillomavirus RNA In Situ Hybridization and p16 Immunostaining in Diagnostically Challenging High-Grade Squamous Intraepithelial Lesions in the Background of Atrophy.
Banet N; Mao Q; Chu S; Ruhul Quddus M
Arch Pathol Lab Med; 2023 Mar; 147(3):323-330. PubMed ID: 35738001
[TBL] [Abstract][Full Text] [Related]
14. [Reliability of the CINtec p16INK4a immunocytochemical test in screening cervical precancerous lesions].
Jović M; Nenadić D; Magić Z; Zoltarevski L; Durdević-Vukomanović B; Tatomirović Z; Strelić N; Vojvodić D
Vojnosanit Pregl; 2008 Mar; 65(3):211-9. PubMed ID: 18494269
[TBL] [Abstract][Full Text] [Related]
15. The role of miR-409-3p in regulation of HPV16/18-E6 mRNA in human cervical high-grade squamous intraepithelial lesions.
Sommerova L; Anton M; Bouchalova P; Jasickova H; Rak V; Jandakova E; Selingerova I; Bartosik M; Vojtesek B; Hrstka R
Antiviral Res; 2019 Mar; 163():185-192. PubMed ID: 30711417
[TBL] [Abstract][Full Text] [Related]
16. High-Grade Squamous Intraepithelial Lesion of the Gastroesophageal Junction Secondary to High-Risk Human Papillomavirus.
Stelow EB; Dill EA; Davick JJ; McCabe MB; Shami VM
Am J Clin Pathol; 2019 Aug; 152(3):359-364. PubMed ID: 31216362
[TBL] [Abstract][Full Text] [Related]
17. Genomic instability in peripheral blood lymphocytes of patients diagnosed with high-grade squamous intraepithelial lesions: CIN 2 versus CIN 3.
Gashi G; Bahtiri E; Podrimaj-Bytyqi A; Morina L; Gashi L; Shabanaj L; Elezaj IR
Mutat Res Genet Toxicol Environ Mutagen; 2020; 854-855():503202. PubMed ID: 32660826
[TBL] [Abstract][Full Text] [Related]
18. Worsening of high-grade squamous intraepithelial lesion (HSIL) with pubic hair removal.
García-Souto F; Pérez-Gil A; Peña-Sánchez R; Escudero-Ordoñez J
Int J Dermatol; 2020 Feb; 59(2):e46-e48. PubMed ID: 31646621
[No Abstract] [Full Text] [Related]
19. Clinicopathological Characteristics of Pleomorphic High-Grade Squamous Intraepithelial Lesion of the Uterine Cervix: A Single-Institutional Series of 31 Cases.
Kim H; Choi S; Do SI; Lee SH; Yoon N; Kim HS
Diagnostics (Basel); 2020 Aug; 10(8):. PubMed ID: 32824242
[TBL] [Abstract][Full Text] [Related]
20. p16/ki67 and E6/E7 mRNA Accuracy and Prognostic Value in Triaging HPV DNA-Positive Women.
Giorgi Rossi P; Carozzi F; Ronco G; Allia E; Bisanzi S; Gillio-Tos A; De Marco L; Rizzolo R; Gustinucci D; Del Mistro A; Frayle H; Confortini M; Iossa A; Cesarini E; Bulletti S; Passamonti B; Gori S; Toniolo L; Barca A; Bonvicini L; Mancuso P; Venturelli F; Benevolo M;
J Natl Cancer Inst; 2021 Mar; 113(3):292-300. PubMed ID: 32745170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
